Cognosetta, Inc.

Tampa, FL · Biotech · Defunct

BK channel opener small molecules for tinnitus treatment

cognosetta.com →
Grants
$263K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
1
0 granted · 1 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Developing a novel therapeutic for treating tinnitus$263,178
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2203BIOPROCESSING INNOVATIVE COMPANY INC——
2204ArCHitect Therapeutics——
2205SHAL TECHNOLOGIES, INC.——
2206Cognosetta, Inc.——
2207RJS Biologics L.L.C.——
2208TRAVERSE BIOSCIENCES, INC.——
2209ARIETIS CORPORATION——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 1
  • Drug For Treating Tinnitusapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.